JP2002519008A - Ｔｅｆ−３活性を阻害するための方法 - Google Patents

Ｔｅｆ−３活性を阻害するための方法

Info

Publication number
JP2002519008A
JP2002519008A JP2000556746A JP2000556746A JP2002519008A JP 2002519008 A JP2002519008 A JP 2002519008A JP 2000556746 A JP2000556746 A JP 2000556746A JP 2000556746 A JP2000556746 A JP 2000556746A JP 2002519008 A JP2002519008 A JP 2002519008A
Authority
JP
Japan
Prior art keywords
tef
binding
gene
cdna
activity
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
JP2000556746A
Other languages
English (en)
Japanese (ja)
Inventor
ハワード ティンダル マイケル
リー ワン リチャード
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Procter and Gamble Co
Original Assignee
Procter and Gamble Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Procter and Gamble Co filed Critical Procter and Gamble Co
Publication of JP2002519008A publication Critical patent/JP2002519008A/ja
Withdrawn legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Physical Education & Sports Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Rheumatology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Peptides Or Proteins (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
JP2000556746A 1998-06-30 1999-06-30 Ｔｅｆ−３活性を阻害するための方法 Withdrawn JP2002519008A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US9131898P 1998-06-30 1998-06-30
US60/091,318 1998-06-30
PCT/US1999/014829 WO2000000161A2 (en) 1998-06-30 1999-06-30 Methods for identification of tef-3 interacting factors

Publications (1)

Publication Number Publication Date
JP2002519008A true JP2002519008A (ja) 2002-07-02

Family

ID=22227169

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2000556746A Withdrawn JP2002519008A (ja) 1998-06-30 1999-06-30 Ｔｅｆ−３活性を阻害するための方法

Country Status (7)

Country Link
EP (1) EP1089794A2 (xx)
JP (1) JP2002519008A (xx)
AU (1) AU5086699A (xx)
CA (1) CA2332121A1 (xx)
IL (1) IL140058A0 (xx)
NO (1) NO20006198L (xx)
WO (1) WO2000000161A2 (xx)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2003001906A1 (fr) * 2001-06-27 2003-01-09 Takeda Chemical Industries, Ltd. Procede de construction d'un modele animal de maladie des articulations

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5824794A (en) * 1994-12-23 1998-10-20 Syntex (U.S.A.) Inc. Human stromelysin-1 promoter
US5569588A (en) * 1995-08-09 1996-10-29 The Regents Of The University Of California Methods for drug screening
EP0935753A4 (en) * 1996-10-31 1999-12-08 Merck & Co Inc TEST ARRANGEMENT AND CELL LINE FOR IDENTIFYING MIMETICS OF GROWTH HORMONES
US6200760B1 (en) * 1997-02-24 2001-03-13 Cornell Research Foundation, Inc. Method of screening agents as candidates for drugs or sources of drugs

Also Published As

Publication number Publication date
EP1089794A2 (en) 2001-04-11
WO2000000161A3 (en) 2001-01-04
CA2332121A1 (en) 2000-01-06
NO20006198L (no) 2001-02-28
NO20006198D0 (no) 2000-12-06
WO2000000161A2 (en) 2000-01-06
AU5086699A (en) 2000-01-17
IL140058A0 (en) 2002-02-10

Similar Documents

Publication Publication Date Title
JP4625602B2 (ja) ミオスタチン遺伝子プロモータおよびその活性化阻害
JP2009213490A (ja) 骨及び／又は関節疾患関連遺伝子
JP2000509967A (ja) カルシウムチャンネルモジュレーターとして活性のあるアセチルコリンエステラーゼの可溶形態からのペプチド
JP2003517836A (ja) 哺乳動物蛋白質ホスファターゼ
CA2344550A1 (en) Expression analysis of specific nucleic acids and polypeptides useful in the diagnosis and treatment of prostate cancer
JPWO2007026969A1 (ja) 創薬標的タンパク質及び標的遺伝子、並びにスクリーニング方法
JP2002526099A (ja) Ｎｌｋ１−相互作用タンパク質
EP1432792B1 (en) Histone deacetylase 9
JP4975444B2 (ja) 創薬標的タンパク質及び標的遺伝子、並びにスクリーニング方法
JP2001523455A (ja) Ｃｄｋ２タンパク質およびｃｄｋ２タンパク質複合体
JP2002529051A (ja) ヘルペスウイルス侵入メディエーター関連タンパク質ファミリーの新規分子およびその使用
JP2006524497A (ja) 骨関節炎のための高処理量機能的ゲノムスクリーニング法
JP2003523723A (ja) ヘルマンスキー−パドラック症候群タンパク質相互作用タンパク質およびその使用の方法
JP2002519008A (ja) Ｔｅｆ−３活性を阻害するための方法
PT90019B (pt) Processo para a preparacao e purificacao de factor de choque termico humano
US20020102614A1 (en) Use of ZPR1 as a molecular probe for spinal muscular atrophy
JPH10502252A (ja) Ｄｐ−１及びその他のｄｐタンパク質の阻害剤のアッセイ
JPH11501817A (ja) ヒト臍静脈内皮細胞で発現されるヒアルロン酸レセプタ
JPH11506023A (ja) 新規ディスインテグリンメタロプロテアーゼおよび使用法
WO1994009037A9 (en) A NEW CLASS OF RPTPases: THEIR STRUCTURAL DOMAINS AND LIGANDS
JP2003527831A (ja) エンドゼピン様ポリペプチドおよびエンドゼピン様ポリペプチドをコードするポリヌクレオチド
AU5443394A (en) A new class of rptpases: their structural domains and ligands
EP1627051A2 (en) Regulation of acheron expression
JP2003534793A (ja) 哺乳動物蛋白質ホスファターゼ
US20090124002A1 (en) Alpha-1d calcium channel expressed in atrium

Legal Events

Date Code Title Description
A300 Application deemed to be withdrawn because no request for examination was validly filed

Free format text: JAPANESE INTERMEDIATE CODE: A300

Effective date: 20060905